Recursos
Patient-reported outcomes in light of supportive medications in treatment-naïve lung cancer patients.
Related Articles Patient-reported outcomes in light of supportive medications in treatment-naïve lung cancer patients. Support Care Cancer. 2020 Apr;28(4):1809-1816 Authors: Hoang JM, Upadhyay N, Dike DN, Lee J, Johnson ML, Cleeland CS, Mendoza T, Chen H, Trivedi MV Abstract PURPOSE: The impact of supportive medications on patient-reported outcomes (PROs) has not been systematically evaluated. We describe the supportive medications used by treatment-naïve lung cancer patients and assess their association with PROs from MD Anderson Symptom Inventory (MDASI). METHODS: Treatment-naïve lung cancer patients who completed PROs from MDASI at the initial visit to MD Anderson Cancer Center were included. Medications from…
Origen: Patient-reported outcomes in light of supportive medications in treatment-naïve lung cancer patients. – PubMed